Free Trial
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

Ampio Pharmaceuticals logo
$0.18 0.00 (0.00%)
As of 11/6/2026

About Ampio Pharmaceuticals Stock (NYSE:AMPE)

Advanced

Key Stats

Today's Range
$0.18
▼
$0.18
50-Day Range
$0.18
▼
$0.18
52-Week Range
$0.00
▼
$0.64
Volume
N/A
Average Volume
2,326 shs
Market Capitalization
$207.82 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ampio Pharmaceuticals, Inc. is a biotechnology company focused on developing therapies for inflammatory and degenerative diseases. The company has primarily concentrated on osteoarthritis of the knee, a condition that can cause chronic pain and reduced mobility.

Ampio’s lead product candidate has been Ampion, an investigational intra-articular treatment derived from human serum albumin. The company studied Ampion for its potential to reduce pain and inflammation associated with osteoarthritis, including in patients with severe disease. Ampion has not been established as an approved commercial therapy, and the company’s development efforts have been subject to clinical and regulatory setbacks.

Founded in 2010 and headquartered in Englewood, Colorado, Ampio Pharmaceuticals has operated as a clinical-stage biotechnology company serving the U.S. pharmaceutical market. Its activities have centered on research, clinical development and regulatory evaluation rather than the sale of a broad portfolio of marketed products. Publicly available information does not provide sufficient reliable detail to summarize a current leadership team.

AI Generated. May Contain Errors.

Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMPE Stock News Headlines

AMPE Ampio Pharmaceuticals, Inc.
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
Ampio Pharmaceuticals, Inc. (AMPE)
See More Headlines

AMPE Stock Analysis - Frequently Asked Questions

Ampio Pharmaceuticals' stock was trading at $0.0052 at the beginning of 2026. Since then, AMPE stock has increased by 3,421.2% and is now trading at $0.1831.

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) issued its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.40) earnings per share for the quarter, hitting the consensus estimate of ($0.40).

Shares of Ampio Pharmaceuticals reverse split before market open on Tuesday, September 12th 2023.The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ampio Pharmaceuticals investors own include Tesla (TSLA), Ford Motor (F), GE Aerospace (GE), Bionano Genomics (BNGO), Ideanomics (IDEX), NVIDIA (nvda) and Trevena (TRVN).

Company Calendar

Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:AMPE
CIK
1411906
Employees
20
Year Founded
2010

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.05

Miscellaneous

Outstanding Shares
1,135,000
Free Float
1,098,000
Market Cap
$207.82 thousand
Optionable
No Data
Beta
5.96

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NYSE:AMPE) was last updated on 11/6/2026 by MarketBeat.com Staff.
From Our Partners